Study Details A Phase 3 randomized controlled study of REACT in participants with Type 2 Diabetes
Protocol Number REGEN-016
Phase III
Therapeutic Area Nephrology
Subject Types With Medical Condition
Indication Type 2 Diabetes
Principal Investigator A/Prof Jimmy Teo Boon Wee
Investigator Product / Device REACT
Sponsor ProKidney Corp
Top